Preservation of fertility by cryopreservation of ovarian tissue and autologous transplantation of ovarian tissue in women under18 age diagnosed with malignant tumors

Not Applicable

• Conditions: Breast cancer, leukemia, malignant lymphoma (Hodgkin' s and Non-Hodgkin' s), other hematopoietic diseases (hypoplastic anemia, myelodysplastic syndrome, myeloma), sarcoma, systemic lupus erythematosus, rheumatic arthritis and other diseases requiring alkylating agents or radiation therapies.

• Registration Number: JPRN-UMIN000029918
• Lead Sponsor: Mie University Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2017-11-14
• Study Completion: 2022-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: Female
• Target Recruitment: 6

Inclusion Criteria

Not provided

Exclusion Criteria

Cryopreservation and autotransplantation 1 Patients with a high probability of metastasis of the original disease to the ovary 2 Patients with obvious infections 3 Patients with severe uncontrollable complications 4 Patients whose doctor judges that this study is inappropriate for participation

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pregnancy rate by autologous transplantation of cryopreserved ovarian tissue